✦ LIBER ✦

8539 Induction chemotherapy with docetaxel, cisplatin and S-1 (TPS) followed by proton therapy concurrent with cisplatin in the patients with T4 nasal cavity cancer

✍ Scribed by Okano, S.; Tahara, M.; Zenda, S.; Kawashima, M.; Ogino, T.; Fuse, N.; Yoshino, T.; Doi, T.; Ohtsu, A.

Book ID: 122420049
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 49 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71630-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction Chemotherapy With Cetuximab, V

Induction Chemotherapy With Cetuximab, Vinorelbine-Cisplatin Followed by Intensity Modulated Thoracic Radiation Therapy and Concurrent Cetuximab, Vinorelbine-Cisplatin in Patients With Unresectable Stage III Non-small Cell Lung Cancer

✍ Di, L.; Min, F.; Jia Yan, C.; Yu Xin, S.; Li Yi, X.; Wei Xin, Z.; Xiao Long, F.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Organ Preservation for Patients With Adv

Organ Preservation for Patients With Advanced Laryngeal Cancer Who Responded to Induction Chemotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil (TPF) Followed by Cisplatin Concomitant With Radiation Therapy: A Phase 2 Trial

✍ Popovtzer, A.; Shvero, J.; Limon, D.; Burnstien, H.; Groshar, D.; Stemmer, S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Docetaxel, cisplatin, and fluorouracil i

Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216)

✍ David J. Adelstein; James Moon; Ehab Hanna; P. G. Shankar Giri; Glenn M. Mills; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract ## Background In an effort to optimize nonoperative therapy in patients with locoregionally advanced head and neck squamous cell cancer, the Southwest Oncology Group conducted a phase II trial combining 3‐drug taxane‐containing induction chemotherapy with accelerated fractionation/conc

P-212 Phase II study of induction chemot

P-212 Phase II study of induction chemotherapy with gemcitabineand vinorelbine followed by concurrent chemotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small cell lung cancer

✍ Lee, D.; Cho, K.; Han, J.; Pyo, H.; Kim, H.; Yoon, S.; Lee, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Phase I trial of split-dose induction do

Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)

✍ Katrin Oertel, Karin Spiegel, Harald Schmalenberg, Andreas Dietz, Georg Maschmey 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 218 KB